Today (13th), the National Health Insurance Administration announced
2023 National Medical Insurance Drug List Adjustment Results
126 new drugs were added to the catalog
Among them, there are 17 kinds of new crown and anti-infective drugs
Diabetes, psychiatric disorders, rheumatism, immunity, etc
There are 15 kinds of drugs for chronic diseases
There are 15 kinds of drugs for rare diseases
Average price reduction: 61.7%
At this year's medical insurance catalogue drug negotiation site
Negotiators of the National Health Insurance Administration and corporate negotiators
Expand multiple "PK"
In the negotiation of a drug for the treatment of diabetes
Reproduction of "Soul Bargging"
This drug was developed by a Chinese pharmaceutical company
And the original innovative drug that was first launched in China
Validated prior to launch
Patients can stop taking the drug for one year after 52 weeks of effectiveness
Previously, the price of the drug was 15 yuan
Be a corporate negotiator
When the first round of quotation is 5.54 yuan
Li Xuri, a medical insurance negotiator, said bluntly
"Medicare services are OK
Promote the R&D and marketing of innovative drugs
I hope that the enterprise side will have greater sincerity"
Subsequently, the corporate negotiators left the venue to discuss
Call for instructions
In the second round, an offer of $5.52 was given
Representatives of the enterprise said that twelve years ago when it was developed
The drug code is HMS552
552, homonym "I I love"
But Li Xuri calculated an account on the spot
"It's two cents down
But calculated at a price of 5.52 yuan
Two pieces a day, more than 330 yuan a month
There are more than 3,000 yuan a year
I hope that enterprises will consider the affordability of the medical insurance fund"
Since then, the company has made every round of quotations
Li Xuri has repeatedly fought for room for price reduction
"I have enough patience to talk step by step"
"Can you build on that
A little bit more force"
"Let's go down a little more......
5.54 yuan→ 5.52 yuan→ 5.49 yuan
The two sides negotiated intensively over a small price range
Finally, the representative of the enterprise left the table again to ask for instructions
Decided to drop another dime
An offer of $5.39 was given
With Li Xuri announcing "successful negotiations"
The negotiations have finally come to an end
Although the transaction price of this drug
This is only $0.15 less than the initial offer
But even if it's just a penny less
It will also bring benefits to thousands of patients
Behind the dime and a half "calculating" bargaining
It is the single-minded protection of patients!
CCTV reporter / Zhang Ping, Zheng Yizhe, Hao Liang, Huang Yichen
Source: CCTV News WeChat public account